Table 4 Comparison of the side effect according to the treatment group. Barrow Neurological Institute (BNI) facial hypoesthesia scale: Grade I no facial hypoesthesia, grade II mild facial hypoesthesia, not bothersome, grade III somewhat bothersome facial hypoesthesia, grade IV very bothersome facial hypoesthesia
From: Radiosurgery for classical trigeminal neuralgia: impact of the shot size on clinical outcome
5-mm cone | 6-mm cone | All | |
|---|---|---|---|
Number of cases | 43 | 52 | 95 |
Cases with at least one grade ≥ 2 toxicity | 15 (34.9%) | 37 (71.1%) | 52 (54.7%) |
Hypoesthesia | |||
I (no hypoesthesia) | 33 (76.7%) | 22 (42.3%) | 55 (57.9%) |
II | 3 (7.0%) | 17 (32.7%) | 20 (21.1%) |
III | 7 (16.3%) | 11 (21.2%) | 18 (18.9%) |
IV | 0 (0%) | 2 (3.8%) | 2 (2.1%) |
Paresthesia | |||
Yes | 10 (23.2%) | 17 (32.7%) | 27 (28.4%) |
No | 33 (76.8%) | 35 (67.3%) | 68 (71.6%) |
Neuropathic pain | |||
Yes | 0 (0%) | 2 (3.8%) | 2 (2.1%) |
No | 43 (100%) | 50 (96.2%) | 93 (97.9%) |
Jaw dysfunction | |||
Yes | 2 (4.7%) | 11 (21.1%) | 13 (13.7%) |
No | 41 (95.3%) | 41 (78.9%) | 82 (86.3%) |